Company Overview of XO1 Ltd.
XO1 Ltd. develops and markets antibodies, ichorcumab. The company was incorporated in 2013 and is based in Cambridge, United Kingdom. As of March 18, 2015, XO1 Ltd. operates as a subsidiary of Janssen Pharmaceuticals, Inc.
Founded in 2013
Key Executives for XO1 Ltd.
Similar Private Companies By Industry
|Achilles Therapeutics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact XO1 Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.